用于肺部mRNA递送和基因组编辑的纳米颗粒的组合设计。
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing.
作者信息
Li Bowen, Manan Rajith Singh, Liang Shun-Qing, Gordon Akiva, Jiang Allen, Varley Andrew, Gao Guangping, Langer Robert, Xue Wen, Anderson Daniel
机构信息
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
出版信息
Nat Biotechnol. 2023 Oct;41(10):1410-1415. doi: 10.1038/s41587-023-01679-x. Epub 2023 Mar 30.
Abstract
The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for messenger RNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.
摘要
非病毒基因组药物在肺部的应用拓展仍受递送难题的限制。在此，我们利用一个高通量平台，合成并筛选了一个可生物降解的离子izable脂质组合文库，以构建用于信使核糖核酸和CRISPR-Cas9基因编辑器的可吸入递送载体。主要的脂质纳米颗粒适合重复气管内给药，并能在肺上皮细胞中实现高效基因编辑，为先天性肺部疾病的基因治疗提供了途径。
相似文献
1
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing.用于肺部mRNA递送和基因组编辑的纳米颗粒的组合设计。
Nat Biotechnol. 2023 Oct;41(10):1410-1415. doi: 10.1038/s41587-023-01679-x. Epub 2023 Mar 30.
2
Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing.使用拆分-Ugi反应合成可电离脂质聚合物用于各种大小RNA的肺部递送和基因编辑。
Nat Commun. 2025 Apr 29;16(1):4021. doi: 10.1038/s41467-025-59136-z.
3
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.通过调节苯硼酸衍生脂质纳米颗粒与细胞表面唾液酸的界面实现细胞选择性信使 RNA 传递和 CRISPR/Cas9 基因组编辑。
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
4
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.生物可还原脂质和信使 RNA 纳米颗粒实现体内快速高效的 CRISPR/Cas9 基因组编辑。
Adv Mater. 2019 Aug;31(33):e1902575. doi: 10.1002/adma.201902575. Epub 2019 Jun 19.
5
High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.用于优化脂质介导的CRISPR-Cas9在人类细胞中递送策略的高内涵分析平台。
Acta Biomater. 2016 Apr 1;34:143-158. doi: 10.1016/j.actbio.2015.12.036. Epub 2015 Dec 30.
6
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
7
Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.可电离脂质纳米颗粒及冻干制剂的研发，用于高效递送CRISPR-Cas9并进行基因组编辑。
Int J Pharm. 2024 Mar 5;652:123845. doi: 10.1016/j.ijpharm.2024.123845. Epub 2024 Jan 22.
8
Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.使用封装 RNA 的脂质纳米颗粒递送至实体瘤中的 CRISPR/dCas9 系统用于表观遗传学编辑的方案。
Methods Mol Biol. 2024;2842:267-287. doi: 10.1007/978-1-0716-4051-7_14.
9
Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.组合脂质纳米颗粒与化学修饰蛋白在细胞内递送和基因组编辑中的整合应用。
Acc Chem Res. 2019 Mar 19;52(3):665-675. doi: 10.1021/acs.accounts.8b00493. Epub 2018 Dec 26.
10
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.体内 CRISPR/Cas9 治疗的递送方法：进展与挑战。
Expert Opin Drug Deliv. 2018 Sep;15(9):905-913. doi: 10.1080/17425247.2018.1517746. Epub 2018 Sep 12.
引用本文的文献
1
Muscle-targeting LNP vaccines enable potent immune responses against varicella zoster virus.靶向肌肉的脂质纳米颗粒疫苗可引发针对水痘带状疱疹病毒的强效免疫反应。
Drug Deliv Transl Res. 2025 Sep 1. doi: 10.1007/s13346-025-01961-2.
2
Freeze-Drying of mRNA-LNPs Vaccines: A Review.mRNA-脂质纳米颗粒疫苗的冷冻干燥：综述
Vaccines (Basel). 2025 Aug 12;13(8):853. doi: 10.3390/vaccines13080853.
3
Designing lipid nanoparticles using a transformer-based neural network.使用基于Transformer的神经网络设计脂质纳米颗粒。
Nat Nanotechnol. 2025 Aug 15. doi: 10.1038/s41565-025-01975-4.
4
In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery.利用信使核糖核酸递送对人类造血干细胞进行体内基因组编辑以治疗血液疾病
Nat Biomed Eng. 2025 Aug 12. doi: 10.1038/s41551-025-01480-y.
5
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape.限制内体损伤感知可减少脂质纳米颗粒内体逃逸引发的炎症。
Nat Nanotechnol. 2025 Aug 11. doi: 10.1038/s41565-025-01974-5.
6
mRNA vaccines for gastrointestinal cancers: a paradigm shift in treatment.用于胃肠道癌症的mRNA疫苗：治疗领域的范式转变
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 6. doi: 10.1007/s00210-025-04462-8.
7
Systematic screening of excipients to stabilize aerosolized lipid nanoparticles for enhanced mRNA delivery.对辅料进行系统筛选，以稳定雾化脂质纳米颗粒，增强mRNA递送。
RSC Pharm. 2025 Jul 18. doi: 10.1039/d5pm00061k.
8
Machine learning techniques for lipid nanoparticle formulation.用于脂质纳米颗粒制剂的机器学习技术
Nano Converg. 2025 Jul 15;12(1):35. doi: 10.1186/s40580-025-00502-4.
9
Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury.利用V-ATP酶激活的非炎性脂质纳米颗粒增强RNA纳米疗法以治疗慢性肺损伤。
Nat Commun. 2025 Jul 14;16(1):6477. doi: 10.1038/s41467-025-61688-z.
10
Advancements in CRISPR/Cas systems for disease treatment.用于疾病治疗的CRISPR/Cas系统的进展。
Acta Pharm Sin B. 2025 Jun;15(6):2818-2844. doi: 10.1016/j.apsb.2025.05.007. Epub 2025 May 17.
本文引用的文献
1
Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases.新型见解：肺部靶向基因转移在最常见呼吸系统疾病中的治疗潜力。
Cells. 2022 Mar 12;11(6):984. doi: 10.3390/cells11060984.
2
Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes Single-Cell RNA Sequencing.利用单细胞 RNA 测序技术对 AAV 嗜性和 AAV 介导的转录变化进行深度平行分析。
Front Immunol. 2021 Oct 21;12:730825. doi: 10.3389/fimmu.2021.730825. eCollection 2021.
3
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway.腺相关病毒 5 载体递送 CRISPR-Cas9 系统支持在小鼠肺气道中进行有效的基因组编辑。
Mol Ther. 2022 Jan 5;30(1):238-243. doi: 10.1016/j.ymthe.2021.10.023. Epub 2021 Oct 23.
4
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.优化脂质纳米粒用于肺部雾化治疗性 mRNA 的递送。
Nat Biomed Eng. 2021 Sep;5(9):1059-1068. doi: 10.1038/s41551-021-00786-x. Epub 2021 Oct 6.
5
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of .脂质纳米颗粒介导的 Cas9 mRNA 和单链向导 RNA 的共递送达实现了. 的肝脏特异性体内基因组编辑。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2020401118.
6
Host genetics and infectious disease: new tools, insights and translational opportunities.宿主遗传学与传染病：新工具、新见解与新转化机遇。
Nat Rev Genet. 2021 Mar;22(3):137-153. doi: 10.1038/s41576-020-00297-6. Epub 2020 Dec 4.
7
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing.用于体内 mRNA 递送和碱基编辑的功能化脂质样纳米颗粒。
Sci Adv. 2020 Aug 21;6(34). doi: 10.1126/sciadv.abc2315. Print 2020 Aug.
8
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.CRISPR基因疗法：应用、局限性及对未来的启示
Front Oncol. 2020 Aug 7;10:1387. doi: 10.3389/fonc.2020.01387. eCollection 2020.
9
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders.基因组编辑生物大分子递送来治疗肺部遗传疾病。
Adv Drug Deliv Rev. 2021 Jan;168:196-216. doi: 10.1016/j.addr.2020.05.002. Epub 2020 May 13.
10
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver.用于通过白蛋白受体将 mRNA 递送至肝脏的协同脂质组合物。
Nat Commun. 2020 May 15;11(1):2424. doi: 10.1038/s41467-020-16248-y.
Zotero 插件